These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18046427)

  • 21. The controversial role of adenoviral-derived vectors in gene therapy programs: where do we stand?
    Romano G
    Drug News Perspect; 2006 Mar; 19(2):99-106. PubMed ID: 16628265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.
    Coccoris M; Straetemans T; Govers C; Lamers C; Sleijfer S; Debets R
    Expert Opin Biol Ther; 2010 Apr; 10(4):547-62. PubMed ID: 20146634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in liver-directed gene transfer vectors.
    Xia D; Zhang MM; Yan LN
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):332-6. PubMed ID: 15313663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah MK; Vandendriessche T
    Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and genetic therapies for haemophilia.
    Lillicrap D; VandenDriessche T; High K
    Haemophilia; 2006 Jul; 12 Suppl 3():36-41. PubMed ID: 16683995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-viral gene delivery in skeletal muscle: a protein factory.
    Lu QL; Bou-Gharios G; Partridge TA
    Gene Ther; 2003 Jan; 10(2):131-42. PubMed ID: 12571642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cells as vehicles for therapeutic genes to treat liver diseases.
    Prieto J; Fernandez-Ruiz V; Kawa MP; Sarobe P; Qian C
    Gene Ther; 2008 May; 15(10):765-71. PubMed ID: 18385768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah M; Vandendriessche T
    Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted gene delivery to the lung.
    Aneja MK; Geiger JP; Himmel A; Rudolph C
    Expert Opin Drug Deliv; 2009 Jun; 6(6):567-83. PubMed ID: 19450167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for cystic fibrosis lung disease: current status and future perspectives.
    Rosenecker J; Huth S; Rudolph C
    Curr Opin Mol Ther; 2006 Oct; 8(5):439-45. PubMed ID: 17078386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas.
    Urosevic M; Fujii K; Calmels B; Laine E; Kobert N; Acres B; Dummer R
    J Clin Invest; 2007 Oct; 117(10):2834-46. PubMed ID: 17823660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered adenovirus serotypes for overcoming anti-vector immunity.
    Dharmapuri S; Peruzzi D; Aurisicchio L
    Expert Opin Biol Ther; 2009 Oct; 9(10):1279-87. PubMed ID: 19645630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designing nonviral vectors for efficient gene transfer and long-term gene expression.
    Jackson DA; Juranek S; Lipps HJ
    Mol Ther; 2006 Nov; 14(5):613-26. PubMed ID: 16784894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
    Kaneda Y
    Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased virus replication in mammalian cells by blocking intracellular innate defense responses.
    de Vries W; Haasnoot J; van der Velden J; van Montfort T; Zorgdrager F; Paxton W; Cornelissen M; van Kuppeveld F; de Haan P; Berkhout B
    Gene Ther; 2008 Apr; 15(7):545-52. PubMed ID: 18273055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice.
    Tanaka S; Yonemitsu Y; Yoshida K; Okano S; Kondo H; Inoue M; Hasegawa M; Masumoto K; Suita S; Taguchi T; Sueishi K
    Gene Ther; 2007 Jul; 14(13):1017-28. PubMed ID: 17460720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver gene therapy: advances and hurdles.
    Nguyen TH; Ferry N
    Gene Ther; 2004 Oct; 11 Suppl 1():S76-84. PubMed ID: 15454961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.